Michigan Pathology

Congratulations to #UMichPath researchers, Drs. Jolanta Grembecka and Tomasz Cierpicki on their recent @US_FDA approval of the first once-daily oral therapy for relapsed/refractory NPM1-mutant acute myeloid leukemia. “This transformative discovery, grounded in research conducted in the Department of Pathology, marks an important moment for our community. The work of Drs. Grembecka and Cierpicki, now recognized through FDA approval, reflect the strength of our scientific environment and our commitment to improving care for patients. It is meaningful to see U-M Pathology contribute to a therapy that is making a real difference for those with leukemia,” said Charles Parkos, Chair of the Department of Pathology. Read about their work: michmed.org/qNYd4

Scientific discovery often starts with curiosity. 🦠🔬 Dr. Bernard Lo’s journey highlights how persistence and mentorship drive breakthroughs in immunology. michmed.org/5GmXd

Dr. Yi Bao’s path to cancer research began with a painful loss: watching a family member endure chemotherapy for lung cancer, only to gain a few more months of life. That experience drove him to pursue a PhD in cancer biology, and today his work is uncovering new ways to make immunotherapy work for more patients. michmed.org/JDj9r

We’re extremely grateful to receive a PCF Challenge award from @PCFnews. This award will support our project on selective proximity targeting of AR and p300/CBP in prostate cancer, a collaboration with Dr. Shaomeng Wang and @yuanyuan_qiao.

Dr. Yuanyuan Qiao has been named a recipient of the Investigator Grant from the Neuroendocrine Research Foundation (NETRF). This highly selective award supports innovative research to accelerate the development of new treatments and cures for neuroendocrine cancers. We’re proud to celebrate this exciting achievement and the impact her work will have on patients and the future of cancer research! michmed.org/dY9W3

Thank you to our a-MAIZE-ing residents and fellows! You inspire us every day with your commitment to education, research, patient care, and beyond. #UMichPath #GoBlue

After decades at #UMichPath, Dr. Paul Killen reflects on a career defined by discovery, mentorship, and community — and looks ahead to what’s next. 🐎⛰️ Congratulations on your retirement, Dr. Killen! michmed.org/Q9VB2

A national research grant is helping the @UMichMedicine's Rogel Cancer Center develop more precise treatments for Ewing Sarcoma, an aggressive childhood cancer. myumi.ch/bVM7b

We appreciate @Forbes including our first in human, adult RPE stem cell based clinical trial for advanced #maculardegeneration @UMKelloggEye in their story about leading approaches for regenerative medicine for retina disease. forbes.com/sites/juergene…

At #UMichPath, Dr. Jie Luo is advancing research to optimize therapeutic strategies for prostate cancer and beyond. 🔬 Learn more about Dr. Luo’s journey, research, and impact: michmed.org/28wjY

Shoutout to Drs. Julianne Szczepanski and Annette Kim for their recent article on donor-derived cell-free DNA in solid organ transplantation, featured in the @Pathologists! The article provides a practical and forward-looking overview of dd-cfDNA technologies and highlights how these tools are transforming kidney and heart transplant surveillance. Read more: michmed.org/VdVk3

A collaborative team from #UMichPath, @NYUGSOM_Path, and @ArimaGenomics developed FFPE Hi-C, a new method that improves the detection of genomic rearrangements in lymphomas and multiple myeloma using standard pathology samples. Read more: michmed.org/qNmwq

Dr. Sara Stone’s path to medicine wasn’t linear, but it led her to a career she loves: diagnosing complex neurologic disease, working with trainees, and advancing collaborative research at #UMichPath. michmed.org/GQdZJ

A new study, led by U-M researcher Dr. Sriram Venneti (@vennetilab), has found that a specific molecule called itaconate drives the development of ependymomas, the third-most common type of brain tumor in children. Read more about the research: michmed.org/rwGen

"My name is Sophia, and I am a Pediatric Phlebotomist Specialist at @MottChildren's Hospital. The part of my job I enjoy most is successfully obtaining blood from patients with challenging veins, as well as cultivating relationships with patients and their families over time. A lot of folks, not just kiddos, have anxiety surrounding pokes! Getting to help even one person understand that having their blood drawn or port accessed isn’t such a treacherous event makes it worth it. Childhood medical experiences can dictate the care patients choose to receive or not receive for the rest of their lives. I like to think I have a positive impact on how people perceive receiving medical care long after their youth!" #UMichPath #NationalPhlebotomistWeek

"Being a phlebotomist is more than my job. It is my way of connecting, caring, and fighting alongside my patients during some of their most vulnerable moments. I am deeply emotionally involved in my work, and every patient teaches me something about strength, resilience, and humanity. I am also grateful to work with an incredible team of coworkers whose knowledge, compassion, and support help me grow every day and make me more efficient and confident in what I do. My love for photography began as another way to honor people by freezing meaningful, unforgettable moments. I now volunteer twice a year, creating portraits for cancer patients and their families. This is an experience that is both educational and healing for my soul. With 12 years in phlebotomy and over five years behind the camera, I am thankful to do work I love at a place as extraordinary as the University of Michigan." Alexandra, Phlebotomist #UMichPath #NationalPhlebotomistWeek

Congratulations to Dr. Carmen Gherasim (@CGGherasim) and #UMich Emergency Medicine's Dr. Frederick Korley on being featured in CAP TODAY! Check out the article highlighting their work on advancing traumatic brain injury biomarkers to improve emergency care: michmed.org/Vd5kr @Pathologists #UMichPath

A new study, led by U-M researcher Dr. Sriram Venneti @vennetilab, has found that a specific molecule called itaconate drives the development of ependymomas, the third-most common type of brain tumor in children. Learn more about this study: michmed.org/7Kzky.

Today, we honor the life of Regina Ferguson, our beloved Facilities Manager in #UMichPath. Regina was a leader, problem-solver, and friend to all. Her kindness and dedication made our department better every day. She will be deeply missed and forever remembered. michmed.org/WX5Jd

During #PhlebotomyWeek, we celebrate the compassion, skill, and teamwork of our #UMichPath phlebotomists, who play a vital part in patient care thousands of times every day. michmed.org/AQWmV

The lab of Celina Kleer, MD, has received a generous donation from The Dynami Foundation, which recognizes Dr. Kleer (@CelinaKleer) and her lab's dedication to the field and will enable the team to advance research on invasive lobular carcinoma of the breast. michmed.org/XWv5N